Cargando…

lncRNA MIR4435-2HG promotes the progression of liver cancer by upregulating B3GNT5 expression

Several studies have indicated that dysregulation of long non-coding RNAs (lncRNAs) participates in the initiation and progression of cancer. The lncRNA MIR4435-2HG was previously reported to act as an oncogene in human cancer, including liver cancer. However, its role in the pathogenesis in liver c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yungang, Li, Baoguo, Xu, Guoping, Han, Changrui, Xing, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669657/ https://www.ncbi.nlm.nih.gov/pubmed/34859256 http://dx.doi.org/10.3892/mmr.2021.12554

Ejemplares similares

The lncRNA MIR4435-2HG is upregulated in hepatocellular carcinoma and promotes cancer cell proliferation by upregulating miRNA-487a
por: Kong, Qinglei, et al.
Publicado: (2019)

LncRNA MIR4435-2HG predicts poor prognosis in patients with colorectal cancer
por: Ouyang, Wen, et al.
Publicado: (2019)

lncRNA MIR4435-2HG promotes cancer cell migration and invasion in prostate carcinoma by upregulating TGF-β1
por: Zhang, Hui, et al.
Publicado: (2019)

LncRNA MIR4435-2HG inhibits the progression of osteoarthritis through miR-510-3p sponging
por: Liu, Yingli, et al.
Publicado: (2020)

LncRNA MIR4435-2HG is downregulated in osteoarthritis and regulates chondrocyte cell proliferation and apoptosis
por: Xiao, Yu, et al.
Publicado: (2019)

Biological Roles and Pathogenic Mechanisms of LncRNA MIR4435-2HG in Cancer: A Comprehensive Review
por: Chen, Zhou, et al.
Publicado: (2023)

M2 Macrophage-Derived Exosomal lncRNA MIR4435-2HG Promotes Progression of Infantile Hemangiomas by Targeting HNRNPA1
por: Li, Zhiyu, et al.
Publicado: (2023)

LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis
por: Zhu, Lijuan, et al.
Publicado: (2020)

LncRNA MIR4435‐2HG functions as a ceRNA against miR‐125a‐5p and promotes neuroglioma development by upregulating TAZ
por: Shen, Wangzhen, et al.
Publicado: (2021)

lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression
por: Yang, Tao, et al.
Publicado: (2022)

LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling
por: Wang, Haiyong, et al.
Publicado: (2019)

LncRNA MIR4435-2HG mediates cisplatin resistance in HCT116 cells by regulating Nrf2 and HO-1
por: Luo, Ping, et al.
Publicado: (2020)

lncRNA MIR4435‐2HG promoted clear cell renal cell carcinoma malignant progression via miR‐513a‐5p/KLF6 axis
por: Zhu, Kai, et al.
Publicado: (2020)

LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder
por: Pei, Lu, et al.
Publicado: (2023)

LncRNA MIR4435‐2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR‐1224‐5p/TGFBR2 axis
por: Xu, Hongchao, et al.
Publicado: (2020)

LncRNA MIR194-2HG Promotes Cell Proliferation and Metastasis via Regulation of miR-1207-5p/TCF19/Wnt/β-Catenin Signaling in Liver Cancer
por: Xu, Guoping, et al.
Publicado: (2020)

MIR4435-2HG Is a Potential Pan-Cancer Biomarker for Diagnosis and Prognosis
por: Zhong, Chenming, et al.
Publicado: (2022)

Long Noncoding RNA MIR4435-2HG Suppresses Colorectal Cancer Initiation and Progression By Reprogramming Neutrophils
por: Yu, Hongfei, et al.
Publicado: (2022)

Fusobacterium nucleatum promotes epithelial‐mesenchymal transiton through regulation of the lncRNA MIR4435‐2HG/miR‐296‐5p/Akt2/SNAI1 signaling pathway
por: Zhang, Shuwei, et al.
Publicado: (2020)

Knockdown of long noncoding RNA colorectal neoplasia differentially expressed inhibits hepatocellular carcinoma progression by mediating the expression of nuclear autoantigenic sperm protein
por: Zhu, Yungang, et al.
Publicado: (2021)

MIR4435-2HG in exosomes promotes gastric carcinogenesis by inducing M2 polarization in macrophages
por: Li, Chaofeng, et al.
Publicado: (2022)

N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation
por: Zhu, Yiqing, et al.
Publicado: (2023)

Long non-coding RNA MIR4435-2HG: a key molecule in progression of cancer and non-cancerous disorders
por: Ghasemian, Majid, et al.
Publicado: (2022)

mi-R4435-2HG promotes proliferation and inhibits apoptosis of cancer cells in ovarian carcinoma by upregulating ROCK2
por: Hu, Jinghui, et al.
Publicado: (2020)

Identification of Long Non-Coding RNA MIR4435-2HG as a Prognostic Biomarker in Bladder Cancer
por: Hu, Zhiquan, et al.
Publicado: (2022)

Knockdown of lncRNA MIR4435-2HG and ST8SIA1 expression inhibits the proliferation, invasion and migration of prostate cancer cells in vitro and in vivo by blocking the activation of the FAK/AKT/β-catenin signaling pathway
por: Xing, Pengyi, et al.
Publicado: (2021)

Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis
por: Gao, Li-Fei, et al.
Publicado: (2021)

Co-upregulation of miR-31 and its host gene lncRNA MIR31HG in oral squamous cell carcinoma
por: Tu, Hsi-Feng, et al.
Publicado: (2022)

LncRNA-MIR17HG mediated upregulation of miR-17 and miR-18a promotes colon cancer progression via activating Wnt/β-catenin signaling
por: Yuan, Guangwen, et al.
Publicado: (2019)

Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis
por: Dong, Xinhua, et al.
Publicado: (2020)

Protective effect of hepatocyte-enriched lncRNA-Mir122hg by promoting hepatocyte proliferation in acute liver injury
por: Yu, Zhenjun, et al.
Publicado: (2022)

Long non-coding RNA MIR4435-2HG promotes the progression of head and neck squamous cell carcinoma by regulating the miR-383-5p/RBM3 axis
por: Wang, Shu, et al.
Publicado: (2021)

LncRNA MIR22HG promotes osteoarthritis progression via regulating miR-9-3p/ADAMTS5 pathway
por: Long, Hui, et al.
Publicado: (2021)

Polymorphisms in lncRNA MIR2052HG and susceptibility to breast cancer in Chinese population
por: Yang, Hui, et al.
Publicado: (2021)

MIR31HG, a potential lncRNA in human cancers and non-cancers
por: Ruan, Luxi, et al.
Publicado: (2023)

Upregulation of lncRNA ZFAS1 promotes lung adenocarcinoma progression by sponging miR‐1271‐5p and upregulating FRS2
por: Fan, Gang, et al.
Publicado: (2020)

LncRNA MIR155HG Overexpression Promotes Proliferation, Migration, and Chemoresistance in Gastric Cancer Cells
por: Lin, Hong, et al.
Publicado: (2023)

LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1
por: Wei, Sen, et al.
Publicado: (2020)

Hypoxia-Induced LncRNA-MIR210HG Promotes Cancer Progression By Inhibiting HIF-1α Degradation in Ovarian Cancer
por: Liu, Ping, et al.
Publicado: (2021)

LncRNA MIR17HG promotes colorectal cancer liver metastasis by mediating a glycolysis-associated positive feedback circuit
por: Zhao, Senlin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ksovb78867gqoo8dis1rallovd